专利号:US-6605430-B1 优先权日:1998-08-12 标题 :DNA shuffling of monooxygenase genes for production of industrial chemicals 发明人:AFFHOLTER JOSEPH A; DAVIS S CHRISTOPHER; SELIFONOV SERGEY A 权利人:MAXYGEN INC 摘要:This invention provides improved monoxygenases, dehydrogenases, and transferases that are useful for the biocatalytic synthesis of compounds such as α-hydroxycarboxylic acids, and aryl- and alkyl-hydroxy compounds. The polypeptides provided herein are improved in properties such as regioselectivity, enzymatic activity, stereospecificity, and the like. Methods for obtaining recombinant polynucleotides that encode these improved polypeptides are also provided, as are organisms that express the polypeptides and are thus useful for carrying out said biocatalytic syntheses. Also provided by the invention are methods for increasing said solvent resistance of organisms that are used in the synthetic methods.
参考文献:10.1016/0920-1211(92)90052-u 摘要:Löscher W, Wahnschaffe U, Hönack D, Wittfoht W, Nau H. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies. Epilepsy Res. 1992 Dec;13(3):187–98. doi: 10.1016/0920-1211(92)90052-u. 参考文献:10.1007/bf01962705 摘要:Löscher W. Pharmacological, toxicological and neurochemical effects of Δ2(E)-valproate in animals. Pharmaceutisch Weekblad Scientific Edition. 1992 Jun;14(3):139–43. doi: 10.1007/bf01962705. 参考文献:10.1007/bf01962707 摘要:Fabre G, Briot C, Marti E, Montseny J-, Bourrié M, Massé D, Berger Y, Cano J-. Δ2-Valproate biotransformation using human liver microsomal fractions. Pharmaceutisch Weekblad Scientific Edition. 1992 Jun;14(3):146–51. doi: 10.1007/bf01962707. 参考文献:10.1007/bf01962708 摘要:Düsing RH. Single-dose tolerance and pharmacokinetics of 2-n-propyl-2(E)-pentenoate (Δ2(E)-valproate) in healthy male volunteers. Pharmaceutisch Weekblad Scientific Edition. 1992 Jun;14(3):152–8. doi: 10.1007/bf01962708. 参考文献:10.1007/bf01962709 摘要:Gram L. Studies on 2-n-propyl-2(E)-pentenoate (Δ2(E)-valproate) in man. Pharmaceutisch Weekblad Scientific Edition. 1992 Jun;14(3):159–60. doi: 10.1007/bf01962709.